Christine L. Chung
2020
Compensation breakdown
| Non-Equity Incentive Plan | $233,568 |
|---|---|
| Option Awards | $1,061,723 |
| Salary | $480,000 |
| Stock Awards | $1,056,400 |
| Other | $47,916 |
| Total | $2,879,607 |
Chung received $1.1M in option awards, accounting for 37% of the total pay in 2020.
Chung also received $233.6K in non-equity incentive plan, $480K in salary, $1.1M in stock awards and $47.9K in other compensation.
Rankings
In 2020, Christine L. Chung's compensation ranked 4,020th out of 13,090 executives tracked by ExecPay. In other words, Chung earned more than 69.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,020 out of 13,090 | 69th |
Division Manufacturing | 1,619 out of 5,624 | 71st |
Major group Chemicals And Allied Products | 618 out of 2,257 | 73rd |
Industry group Drugs | 533 out of 1,957 | 73rd |
Industry Pharmaceutical Preparations | 407 out of 1,462 | 72nd |
Pay ratio
| Christine L. Chung's Pay | $2,879,607 |
|---|---|
| Median Employee's Pay | $177,952 |
| Pay Ratio | to 1 |
In 2020, the annual total compensation of Christine L. Chung was $2,879,607.
The annual total compensation of the median employee at FibroGen was $177,952.
The ratio of Christine L. Chung's pay to the pay of median employee was therefore to one.
Chung's colleagues
We found seven more compensation records of executives who worked with Christine L. Chung at FibroGen in 2020.
2020
Enrique Conterno
FibroGen
Chief Executive Officer
2020
Thane Wettig
FibroGen
Chief Commercial Officer
2020
Mark Eisner
FibroGen
Chief Medical Officer
2020
K Yu
FibroGen
Chief Medical Officer
2020
Pat Cotroneo
FibroGen
Chief Financial Officer
2020
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
2020
James Schoeneck
FibroGen